Welcome to Markets Desk, your midday read on the stories moving markets and the broader conversation.
On the geopolitical front, analysts at Brookings are warning that Russia and China could grow more assertive if they sense Donald Trump is politically weakened following a Democratic midterm sweep. The argument is straightforward — adversaries tend to test limits when they perceive a lame-duck dynamic in Washington, and that calculus has real implications for defense postures, trade policy, and risk premiums across emerging markets.
Shifting to earnings, Vir Biotechnology posted its third-quarter two thousand twenty-six results, reporting a net loss of ninety-six point three million dollars, or fifty-seven cents per share. That is a meaningful improvement from a loss of one dollar and seventeen cents per share in the same period a year ago, suggesting the biotech is narrowing its burn rate, though it remains firmly in investment mode with no clear path to profitability on the near-term horizon.
And in the semiconductor space, SpaceX has tapped Qualcomm to supply base-station chips and software for tens of thousands of planned Starlink Mobile sites. It is a significant design win for Qualcomm, validating its push beyond handsets and into infrastructure, though analysts are keeping the stock at a hold given valuation and execution risks tied to the sheer scale of the Starlink buildout.
That's the tape. Markets Desk, signing off the floor.
